SHIFTBIO
PrivateLast Round
VC Round
Feb 1, 2024
Company Overview
SHIFTBIO is a biotechnology company that develops a nanoparticle-based drug delivery system designed for targeted therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SHIFTBIO Comparables
Compare SHIFTBIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evox Therapeutics | 83% | |
| ILIAS Biologics Inc. | 81% | |
| Exocure | 79% | |
SHIFTBIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 1, 2024 | ||||
| Accelerator | Jun 3, 2022 |
Key People
Founding team and executive leadership
SHIFTBIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea University Holdings | Accelerator |
| Korea Credit Guarantee Fund | Accelerator |
| Government of South Korea | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 254% MoM.
- Oct 29, 2024
Monthly visitors grew 182% MoM.
SHIFTBIO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SHIFTBIO's valuation, stock price, and market status.